Breathlessness R06 J44 C80 I50 J84 J43
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: i) Patients affected by breathlessness due to any advanced life-limiting and progressive disease, despite treatment of the underlying condition ii) Patients capable (in a cognitive and functional manner) to participate in the intervention including outpatient clinic and physiotherapist visits as well as self- management iii) If patients are suffering from acute exacerbations of the underlying conditions, they are put on a waiting list for two to four weeks and are then entered into the trial.
Exclusion criteria
Exclusion criteria: i) Patients suffering from breathlessness due to chronic hyperventilation syndrome, asthma or any other unknown cause ii) Cancer patients under concurrent initial or full dose systemic treatment or radiotherapy (except on maintenance therapy) iii) Patients participating in any drug trial targeting the treatment of the underlying condition/ illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Mastery of breathlessness 2. Quality of life (both measured on the Chronic Respiratory Disease Questionnaire (CRQ)) 3. Symptom Burden (measured with IPOS) 4. Carer burden (Measured with ZBI - 22 item version). Measurements are taken at all points in time (Baseline, T1, T2, Follow-up) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Breathlessness severity 2. health economic endpoints, 3. survival | — |
Countries
Germany
Contacts
Klinik und Poliklinik für Palliativmedizin, Klinikum der Universität München, Campus Großhadern